About
Recornea develops innovative minimally-invasive nitinol intracorneal implants and medical devices to treat ocular diseases such as keratoconus and glaucoma, aiming to restore vision and prevent blindness.
Explore Recornea's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.